Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
about
Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapyOncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.Inactivated Tianjin strain, a novel genotype of Sendai virus, induces apoptosis in HeLa, NCI-H446 and Hep3B cells.
P2860
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
@en
type
label
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
@en
prefLabel
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
@en
P2093
P2860
P921
P1476
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
@en
P2093
Earl E Henderson
Gaetano Romano
Mingxu Guan
Roberta Coroniti
P2860
P356
10.1186/PREACCEPT-1887479723143655
P577
2014-11-01T00:00:00Z
P6179
1064134468